Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-5_02-cv-01474/USCOURTS-cand-5_02-cv-01474-25/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 35:271 Patent Infringement

---

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

1 

STIPULATION REGARDING SUPPLEMENTAL BRIEFING REGARDING SUMMARY JUDGMENT ISSUES RELATED TO THE 

GUGLIELMI AND [PROPOSED] ORDER -- Case No. C-02-1474 JW 

[SEE SIGNATURE PAGE FOR ATTORNEY NAMES] 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA 

BOSTON SCIENTIFIC CORP. and 

TARGET THERAPEUTICS, INC., 

 Plaintiffs, 

 vs. 

CORDIS CORPORATION, 

 Defendants. 

Case No.: C02-1474-JW 

STIPULATION REGARDING 

SUPPLEMENTAL BRIEFING 

REGARDING SUMMARY JUDGMENT 

ISSUES RELATED TO THE GUGLIELMI 

AND [PROPOSED] ORDER 

 

 Pursuant to the Court’s instruction, Boston Scientific Corp. and Target Therapeutics, Inc. 

(collectively “Boston Scientific”) and Defendant Cordis Corporation hereby submit a proposed 

schedule for filing supplemental briefs to further address issues raised during the October 25, 2006 

hearing on the motions for summary judgment concerning the ‘385 and ‘498 Guglielmi patents. 

The parties do dispute the scope of additional briefing requested by the Court. As set forth in 

Boston Scientific’s opening brief filed on January 12, 2007, it is Boston Scientific’s understanding 

that the Court requested additional briefing only on “infectious unenforceability,” and whether the 

fact that Target charged the University of California, Los Angeles a “nominal fee ” to recoup 

manufacturing and research and development costs concerning the GDC device constitutes an 

invalidating “commercial sale” under 35 U.S.C. § 102(b). Cordis disagrees with Boston 

Scientific’s position and believes that the Court requested briefing on additional issues raised 

concerning Cordis’s contentions of (1) Inequitable Conduct; and (2) Public Use or Sale under 35 

----------------

Case 5:02-cv-01474-JW Document 964 Filed 01/30/07 Page 1 of 3
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

2 

STIPULATION REGARDING SUPPLEMENTAL BRIEFING REGARDING SUMMARY JUDGMENT ISSUES RELATED TO THE 

GUGLIELMI AND [PROPOSED] ORDER -- Case No. C-02-1474 JW 

U.S.C. § 102(b). Cordis contends that the Court sought additional guidance from the parties on 

these topics during the course of the Hearing on October 25, 2006. See e.g. Transcript at pages 67- 

79 and 141- 143. Although the parties do not agree on the scope of the additional briefing (and 

will abide by any further instruction by the Court on this issue), the parties do agree to the 

following briefing schedule: 

DATE EVENT 

1/12/07 Plaintiffs filed and served supplemental 

brief

1/26/07 Defendant files and serves responsive 

brief and supplemental brief on any issues 

not raised by Plaintiffs

2/9/07 Plaintiffs file Reply Brief to Defendant’s 

responsive brief and supplemental brief on 

any remaining issues not raised by 

Defendant

2/16/07 Defendant files and serves Reply Brief to 

Plaintiffs’ supplemental brief 

The Court also instructed the parties’ to submit a joint statement of facts in connection 

with the parties cross-motions for summary judgment of validity/invalidity of the “radio-opaque” 

marker claims of the ‘385 and ‘498 patents. The parties propose the following schedule: 

DATE EVENT 

1/15/07 Plaintiffs served Defendants with 

proposed statement of facts

2/2/07 Defendant serves Plaintiffs with counterproposed statement of facts

2/16/07 Parties file Joint Statement of Facts 

indicting which facts, if any, are disputed

DATED: January 26, 2007 BOSTON SCIENTIFIC CORP. 

and TARGET THERAPEUTICS, INC. 

By: ___/s/_____________________ 

FOLGER LEVIN & KAHN LLP 

Michael F. Kelleher (SB#165493) 

Julie L. Fieber (SB#202857) 

Embarcadero Center West 

Case 5:02-cv-01474-JW Document 964 Filed 01/30/07 Page 2 of 3
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

3 

STIPULATION REGARDING SUPPLEMENTAL BRIEFING REGARDING SUMMARY JUDGMENT ISSUES RELATED TO THE 

GUGLIELMI AND [PROPOSED] ORDER -- Case No. C-02-1474 JW 

275 Battery Street, 23rd Floor 

San Francisco, CA 94111 

Telephone: (415) 986-2800 

Fax: (415) 986-2827 

J. Anthony Downs (Pro Hac Vice) 

Roland H. Schwillinski (Pro Hac Vice) 

Amanda M. Kessel (Pro Hac Vice) 

GOODWIN PROCTER LLP 

Exchange Place 

Boston, Massachusetts 02109-2881 

Tel: (617) 570-1000 

Fax: (617) 523-1231 

 CORDIS CORPORATION 

Edward V. Anderson 

 Matthew T. Powers 

Georgia K. Van Zanten 

Teague I. Donahey 

SIDLEY AUSTIN LLP 

555 California St., Suite 5000 

San Francisco, CA 94104-1715 

Telephone: (415) 772-1200 

Facsimile: (415) 397-4621 

David T. Pritikin (Pro Hac Vice) 

Hugh A. Abrams (Pro Hac Vice) 

Lisa A. Schneider (Pro Hac Vice) 

Stephanie P. Koh (Pro Hac Vice) 

SIDLEY AUSTIN LLP 

One S. Dearborn St. 

Chicago, IL 60603 

Telephone: (312) 853-7000 

Facsimile: (312) 853-7036 

Eric I. Harris (Of Counsel) 

CORDIS CORPORATION 

One Johnson & Johnson Plaza 

New Brunswick, NJ 08933 

Telephone: (732) 524-2444 

 Facsimile: (732) 524-2788 

[PROPOSED] ORDER 

Pursuant to stipulation, IT IS SO ORDERED 

Dated: __________ ______________________________________ 

Hon. James Ware 

United States District Judge

 Northern District of California 

1/30/2007 ----------------

Case 5:02-cv-01474-JW Document 964 Filed 01/30/07 Page 3 of 3